Oral microbiome and SARS-CoV-2: beware of lung co-infection
L Bao, C Zhang, J Dong, L Zhao, Y Li… - Frontiers in microbiology, 2020 - frontiersin.org
The new coronavirus SARS-CoV-2, the cause of COVID-19, has become a public health
emergency of global concern. Like the SARS and influenza pandemics, there have been a …
emergency of global concern. Like the SARS and influenza pandemics, there have been a …
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
H Li, C Chen, F Hu, J Wang, Q Zhao, RP Gale, Y Liang - Leukemia, 2020 - nature.com
We performed a meta-analysis to determine safety and efficacy of corticosteroids in SARS-
CoV-2, SARS-CoV, and MERS-CoV infections. We searched PubMed, Web of Science …
CoV-2, SARS-CoV, and MERS-CoV infections. We searched PubMed, Web of Science …
[PDF][PDF] Novel coronavirus COVID-19: an overview for emergency clinicians
AL Giwa, A Desai - Emerg Med Pract, 2020 - ebmedicine.net
Coronaviruses earn their name from the characteristic crown-like viral particles (virions) that
dot their surface. This family of viruses infects a wide range of vertebrates, most notably …
dot their surface. This family of viruses infects a wide range of vertebrates, most notably …
Clinical features of covid-19
P Vetter, DL Vu, AG L'Huillier, M Schibler, L Kaiser… - Bmj, 2020 - bmj.com
In January 2020, coronavirus SARS-CoV-2 was identified as the cause of an outbreak of
severe pneumonia, now known to be a complication of the coronavirus disease 2019 (covid …
severe pneumonia, now known to be a complication of the coronavirus disease 2019 (covid …
Potential neurological symptoms of COVID-19
HY Wang, XL Li, ZR Yan, XP Sun… - Therapeutic …, 2020 - journals.sagepub.com
Due to a lack of clear and specific clinical symptoms in the patients mentioned above,
diagnosis of COVID-19 is especially challenging, which may lead to missed or erroneous …
diagnosis of COVID-19 is especially challenging, which may lead to missed or erroneous …
Can nanotechnology and materials science help the fight against SARS-CoV-2?
Since 2004, we have been developing nanomaterials with antimicrobial properties, the so-
called nanoantimicrobials. When the coronavirus disease 2019 (COVID-19) emerged, we …
called nanoantimicrobials. When the coronavirus disease 2019 (COVID-19) emerged, we …
Extrapulmonary complications of COVID‐19: A multisystem disease?
The outbreak of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has been recently declared a pandemic …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has been recently declared a pandemic …
Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 …
Background Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the
severe acute respiratory syndrome coronavirus 2 started to spread globally since December …
severe acute respiratory syndrome coronavirus 2 started to spread globally since December …
Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: a meta-analysis
Background In this systematic review and meta-analysis, we aimed to explore the
association between cardiac injury and mortality, the need for intensive care unit (ICU) care …
association between cardiac injury and mortality, the need for intensive care unit (ICU) care …
COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection
In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …